Sponsor Dossier
CSL Behring
Sponsor Dossier for CSL Behring. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: “TBSF”
- Brand: AFSTYLA
- Brand: ALBUMEX
- Brand: ALBUNATE
- Brand: ALBUREX
- Brand: ALEVIATE
- Brand: ANDEMBRY
- Brand: BERINERT
- Device (sponsor): Medication transfer set
- Device (sponsor): Medication transfer set
- Device (sponsor): Medication transfer set
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Medication transfer set
- Device (sponsor): Medication transfer set
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
- Device (sponsor): Basic intravenous administration set, invasive
- Device (sponsor): Medicine administration kit, percutaneous, medicated, single-use
About
CSL Behring is an Australian Private Company with ABN 48 160 734 761, registered in Victoria. The entity is currently active.
Portfolio
CSL Behring has 22 brands on the ARTG, of which 18 are indexable. The portfolio includes 16 brands with Product Information on file. One brand has at least one PBS-listed item, one brand has PBAC outcome(s) on record, and four brands have AusPAR(s) on record.
Therapeutic focus —
Haematology: 13 brands — Immunology: 4 brands — Cardiology: 2 brands — Oncology: 1 brand — Neurology: 1 brand — Complementary Medicine: 1 brand
PBS footprint
One brand in the CSL Behring portfolio is PBS-listed, with the latest PBS schedule date their portfolio touched being 2026-05-01.
Regulatory activity
CSL Behring has one brand with a PBAC outcome on record, with the latest outcome dated 2024-11-01. Four brands have AusPAR(s) on record, with the latest AusPAR dated 2025-01-09.